Compare · ALB vs ASPI
ALB vs ASPI
Side-by-side comparison of Albemarle Corporation (ALB) and ASP Isotopes Inc. (ASPI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALB and ASPI operate in Major Chemicals (Industrials), so they compete in similar markets.
- ALB is the larger of the two at $18.02B, about 22.4x ASPI ($805.8M).
- Over the past year, ALB is up 132.3% and ASPI is down 31.2% - ALB leads by 163.5 points.
- ASPI has been more active in the news (9 items in the past 4 weeks vs 4 for ALB).
- ALB has more recent analyst coverage (25 ratings vs 3 for ASPI).
- Company
- Albemarle Corporation
- ASP Isotopes Inc.
- Price
- $149.17-2.36%
- $6.00-5.88%
- Market cap
- $18.02B
- $805.8M
- 1M return
- -28.97%
- -3.62%
- 1Y return
- +132.32%
- -31.21%
- Industry
- Major Chemicals
- Major Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2022
- News (4w)
- 4
- 9
- Recent ratings
- 25
- 3
Albemarle Corporation
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
Latest ALB
- Albemarle Corporation filed SEC Form 8-K: Leadership Update
- SEC Form SD filed by Albemarle Corporation
- Albemarle upgraded by Vertical Research with a new price target
- Chairman & CEO Masters J Kent sold $3,011,766 worth of shares (16,393 units at $183.72), decreasing direct ownership by 16% to 87,519 units (SEC Form 4)
- SEC Form S-8 filed by Albemarle Corporation
- Albemarle Corporation filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits
- SEC Form 10-Q filed by Albemarle Corporation
- Albemarle Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Albemarle Announces Quarterly Common Stock Dividend
- Albemarle downgraded by Rothschild & Co Redburn with a new price target
Latest ASPI
- Chairman and CEO Mann Paul Elliot was granted 2,233,555 shares and sold $2,004,337 worth of shares (251,275 units at $7.98) as part of a pre-agreed trading plan, increasing direct ownership by 26% to 9,579,845 units (SEC Form 4) (withholding tax)
- Chief Financial Officer Kiessling Heather was granted 840,000 shares, increasing direct ownership by 118% to 1,549,376 units (SEC Form 4)
- Chief Operating Officer Ainscow Robert was granted 800,000 shares, increasing direct ownership by 54% to 2,290,317 units (SEC Form 4)
- EVP, Gen Counsel, Secretary Ainscow Donald George was granted 400,000 shares, increasing direct ownership by 80% to 900,000 units (SEC Form 4)
- SEC Form 144 filed by ASP Isotopes Inc.
- ASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
- ASP Isotopes Implements Engineering Enhancements to Silicon-28 Enrichment Facility; Successfully Restarts First 18 Stages of Silicon-28 Enrichment Facility; Commercial Shipments of Enriched Silicon-28 Expected to Commence in Q3 2026
- ASP Isotopes Inc. filed SEC Form 8-K: Regulation FD Disclosure
- SEC Form 10-Q filed by ASP Isotopes Inc.
- SEC Form NT 10-Q filed by ASP Isotopes Inc.